시장보고서
상품코드
1583043

세계의 마이코플라스마 검사 시장(2024-2028년)

Global Mycoplasma Testing Market 2024-2028

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 177 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

마이코플라스마 검사 시장은 2023-2028년에 7억 4,340만 달러, 예측 기간 중 CAGR은 12.68%로 성장할 것으로 예측됩니다. 마이코플라스마 검사 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 바이오의약품의 연구개발에 대한 주목의 증가, 고령자의 증가, 실시간 마이코플라스마 검사의 채택 증가 등이 촉진하고 있습니다.

시장 범위
기준년 2024년
종료년 2028년
예측 기간 2024-2028년
성장 모멘텀 가속
전년대비[2024년] 11.01%
CAGR 12.68%
증분액 7억 4,340만 달러

본 조사에서는 향후 수년간 마이코플라스마 검사 시장의 성장을 촉진하는 주요 요인의 하나로 벤더에 의한 전략적 제휴의 증가를 들고 있습니다. 또한 마이코플라스마 폐렴의 유병률 상승, 폐렴에 의한 사망률에 대한 우려, 감염증의 신속 진단을 위한 구상의 증가도 시장의 큰 수요로 연결됩니다.

목차

제1장 개요

  • 시장 개요

제2장 시장 구도

  • 시장 에코시스템
  • 시장의 특징
  • 밸류체인 분석

제3장 시장 규모의 평가

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모 2023년
  • 시장 전망 2023-2028년

제4장 시장 규모 실적

  • 세계의 마이코플라스마 검사 시장 2018-2022년
  • 최종사용자별 부문 분석 2018-2022년
  • 제품별 부문 분석 2018-2022년
  • 지역별 부문 분석 2018-2022년
  • 국가별 부문 분석 2018-2022년

제5장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 현황

제6장 최종사용자별 시장 세분화

  • 시장 세분화
  • 비교 : 최종사용자별
  • 제약·바이오테크놀러지 기업 : 시장 규모와 예측 2023-2028년
  • 세포은행 : 시장 규모와 예측 2023-2028년
  • 학술연구기관 : 시장 규모와 예측 2023-2028년
  • CRO : 시장 규모와 예측 2023-2028년
  • 기타 : 시장 규모와 예측 2023-2028년
  • 최종사용자별 시장 기회

제7장 제품별 시장 세분화

  • 시장 세분화
  • 비교 : 제품별
  • 소모품 : 시장 규모와 예측 2023-2028년
  • 시스템 : 시장 규모와 예측 2023-2028년
  • 제품별 시장 기회

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 비교 : 지역별
  • 북미 : 시장 규모와 예측 2023-2028년
  • 유럽 : 시장 규모와 예측 2023-2028년
  • 아시아 : 시장 규모와 예측 2023-2028년
  • 기타 : 시장 규모와 예측 2023-2028년
  • 미국 : 시장 규모와 예측 2023-2028년
  • 영국 : 시장 규모와 예측 2023-2028년
  • 캐나다 : 시장 규모와 예측 2023-2028년
  • 독일 : 시장 규모와 예측 2023-2028년
  • 중국 : 시장 규모와 예측 2023-2028년
  • 지역 상황별 시장 기회

제10장 촉진요인·과제·기회·억제요인

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 촉진요인과 과제의 영향
  • 시장 기회·억제요인

제11장 경쟁 구도

  • 개요
  • 경쟁 구도
  • 혼란 상황
  • 업계 리스크

제12장 경쟁 분석

  • 기업 개요
  • 기업의 시장 포지셔닝
  • Agilent Technologies Inc.
  • ATCC
  • Akron BIoTechnology LLC
  • Becton Dickinson and Co.
  • Bio Techne Corp.
  • Bionique Testing Laboratories Inc.
  • Charles River Laboratories International Inc.
  • F. Hoffmann La Roche Ltd.
  • GeneCopoeia Inc.
  • InvivoGen Corp.
  • Lonza Group Ltd.
  • Merck KGaA
  • Norgen BIoTek Corp.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

제13장 부록

KSA 24.11.13

The mycoplasma testing market is forecasted to grow by USD 743.4 mn during 2023-2028, accelerating at a CAGR of 12.68% during the forecast period. The report on the mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on r and d of biopharmaceuticals, growing geriatric population, and rise in adoption of real-time mycoplasma testing.

Technavio's mycoplasma testing market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202411.01%
CAGR12.68%
Incremental Value$743.4 mn

By End-user

    • Pharmaceutical and biotechnology companies
    • Cell banks
    • Academic research institutes
    • CROs
    • Others

By Product

    • Consumables
    • Systems

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the rising strategic alliances by vendors as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, rising prevalence of mycoplasma pneumonia and concerns associated with pneumonia mortality and increasing initiatives for rapid diagnostics of infectious diseases will lead to sizable demand in the market.

The report on the mycoplasma testing market covers the following areas:

    • Mycoplasma testing market sizing
    • Mycoplasma testing market forecast
    • Mycoplasma testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Akron Biotechnology LLC, Becton Dickinson and Co., Bio Techne Corp., Bionique Testing Laboratories Inc., Charles River Laboratories International Inc., DiaSorin SpA, Dilarus GmbH, F. Hoffmann La Roche Ltd., GeneCopoeia Inc., InvivoGen Corp., Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., PromoCell GmbH, Sartorius AG, ScienCell Research Laboratories Inc., SGS SA, and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Mycoplasma Testing Market 2018 - 2022
    • Historic Market Size - Data Table on Global Mycoplasma Testing Market 2018 - 2022 ($ million)
  • 4.2 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.3 Product segment analysis 2018 - 2022
    • Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

  • 6.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 6.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
    • Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
    • Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
    • Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
    • Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
  • 6.4 Cell banks - Market size and forecast 2023-2028
    • Chart on Cell banks - Market size and forecast 2023-2028 ($ million)
    • Data Table on Cell banks - Market size and forecast 2023-2028 ($ million)
    • Chart on Cell banks - Year-over-year growth 2023-2028 (%)
    • Data Table on Cell banks - Year-over-year growth 2023-2028 (%)
  • 6.5 Academic research institutes - Market size and forecast 2023-2028
    • Chart on Academic research institutes - Market size and forecast 2023-2028 ($ million)
    • Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ million)
    • Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
    • Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
  • 6.6 CROs - Market size and forecast 2023-2028
    • Chart on CROs - Market size and forecast 2023-2028 ($ million)
    • Data Table on CROs - Market size and forecast 2023-2028 ($ million)
    • Chart on CROs - Year-over-year growth 2023-2028 (%)
    • Data Table on CROs - Year-over-year growth 2023-2028 (%)
  • 6.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
    • Chart on Product - Market share 2023-2028 (%)
    • Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 7.3 Consumables - Market size and forecast 2023-2028
    • Chart on Consumables - Market size and forecast 2023-2028 ($ million)
    • Data Table on Consumables - Market size and forecast 2023-2028 ($ million)
    • Chart on Consumables - Year-over-year growth 2023-2028 (%)
    • Data Table on Consumables - Year-over-year growth 2023-2028 (%)
  • 7.4 Systems - Market size and forecast 2023-2028
    • Chart on Systems - Market size and forecast 2023-2028 ($ million)
    • Data Table on Systems - Market size and forecast 2023-2028 ($ million)
    • Chart on Systems - Year-over-year growth 2023-2028 (%)
    • Data Table on Systems - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.9 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Agilent Technologies Inc.
    • Agilent Technologies Inc. - Overview
    • Agilent Technologies Inc. - Business segments
    • Agilent Technologies Inc. - Key news
    • Agilent Technologies Inc. - Key offerings
    • Agilent Technologies Inc. - Segment focus
  • 12.4 ATCC
    • ATCC - Overview
    • ATCC - Product / Service
    • ATCC - Key offerings
  • 12.5 Akron Biotechnology LLC
    • Akron Biotechnology LLC - Overview
    • Akron Biotechnology LLC - Product / Service
    • Akron Biotechnology LLC - Key offerings
  • 12.6 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
  • 12.7 Bio Techne Corp.
    • Bio Techne Corp. - Overview
    • Bio Techne Corp. - Business segments
    • Bio Techne Corp. - Key news
    • Bio Techne Corp. - Key offerings
    • Bio Techne Corp. - Segment focus
  • 12.8 Bionique Testing Laboratories Inc.
    • Bionique Testing Laboratories Inc. - Overview
    • Bionique Testing Laboratories Inc. - Product / Service
    • Bionique Testing Laboratories Inc. - Key offerings
  • 12.9 Charles River Laboratories International Inc.
    • Charles River Laboratories International Inc. - Overview
    • Charles River Laboratories International Inc. - Business segments
    • Charles River Laboratories International Inc. - Key offerings
    • Charles River Laboratories International Inc. - Segment focus
  • 12.10 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 12.11 GeneCopoeia Inc.
    • GeneCopoeia Inc. - Overview
    • GeneCopoeia Inc. - Product / Service
    • GeneCopoeia Inc. - Key offerings
  • 12.12 InvivoGen Corp.
    • InvivoGen Corp. - Overview
    • InvivoGen Corp. - Product / Service
    • InvivoGen Corp. - Key offerings
  • 12.13 Lonza Group Ltd.
    • Lonza Group Ltd. - Overview
    • Lonza Group Ltd. - Business segments
    • Lonza Group Ltd. - Key news
    • Lonza Group Ltd. - Key offerings
    • Lonza Group Ltd. - Segment focus
  • 12.14 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
  • 12.15 Norgen Biotek Corp.
    • Norgen Biotek Corp. - Overview
    • Norgen Biotek Corp. - Product / Service
    • Norgen Biotek Corp. - Key offerings
  • 12.16 Sartorius AG
    • Sartorius AG - Overview
    • Sartorius AG - Business segments
    • Sartorius AG - Key news
    • Sartorius AG - Key offerings
    • Sartorius AG - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
    • Thermo Fisher Scientific Inc. - Overview
    • Thermo Fisher Scientific Inc. - Business segments
    • Thermo Fisher Scientific Inc. - Key news
    • Thermo Fisher Scientific Inc. - Key offerings
    • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제